Presentation of three cases of primary renal sarcomas
Palabras clave:
renal malignancies, sarcoma, nephrectomy, disease progression, prognosisResumen
A retrospective review of cases of primary renal sarcomas diagnosed between 1995 and 2020 at the University Hospital of Getafe (Spain) was carried out, with the aim of contrasting the clinical-pathological characteristics, treatment and evolution. Primary renal sarcomas account for 0.58 % of all renal tumors diagnosed at this institution. All patients were treated by excision of the tumor mass. Two patients had localized disease at the time of diagnosis and one of them had metastatic disease. Two of the patients had recurrence and died. The time of progression was 3.7 months. The median survival time was 9.45 months. Primary renal sarcomas are very rare neoplasms. The treatment of choice is surgery, recurrence is very common and the overall prognosis is poor.
Descargas
Los datos de descargas todavía no están disponibles.
Citas
1. Mullen JT, Delaney TF. Clinical features, evaluation, and treatment of retroperitoneal soft tissue sarcoma. UpToDate. 2022 [access 22/08/2022]. Available from: https://www-uptodate-com.m-hug.a17.csinet.es/contents/clinical-features-evaluation-and-treatment-of-retroperitoneal-soft-tissue-sarcoma/print
2. Tahri R, Gamra L, El Otmany A. Liposarcome de la loge rénale: à propos de deux cas avec revue de la littérature. PAMJ. 2018;29:167. DOI: 10.11604/pamj.2018.29.167.1850
3. Messiou C, Moskovic E, Vanel D, Morosi C, Benchimol R, Strauss D, et al. Primary Retroperitoneal Soft Tissue Sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. Eur J Surg Oncol. 2017;43(7):1191-8. DOI: 10.1016/j.ejso.2016.10.032
4. Sierra Labarta R, Gil Sanz MJ, Muñoz González G, Rioja Sanz LA. Un nuevo caso de histiocitoma fibroso maligno dependiente de cápsula renal. Actas Urol Esp. 2010 [access 22/08/2022];34(1):122-4. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062010000100023&lng=es
5. Yilmaz C, Kabatas S, Ozen OI, Gulsen S, Caner H, Altinors N. Solitary fibrous tumor. J Clin Neurosci. 2009;16(12):1578-81. DOI: 10.1016/j.jocn.2009.02.039
6. Demicco EG, Meyer C. Solitary fibrous tumor. UpToDate. 2022 [access 22/08/2022]. Available from: https://www.uptodate.com/contents/solitary-fibrous-tumor
7. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416-21. DOI: 10.1097/sla.0000000000000869
8. Trans-Atlantic RPS Working Group. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256-63. DOI: 10.1245/s10434-014-3965-2
9. Tiong SS, Dickie C, Haas RL, O’Sullivan B. The role of radiotherapy in the management of localized soft tissue sarcomas. Cancer Biol Med. 2016;13(3):373-83. DOI: 10.20892/j.issn.2095-3941.2016.0028
10. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, et al. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018;18(1):913. DOI: 10.1186/s12885-018-4829-0
11. Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy. J Surg Oncol. 2018;117(1):99-104. DOI: 10.1002/jso.24927
2. Tahri R, Gamra L, El Otmany A. Liposarcome de la loge rénale: à propos de deux cas avec revue de la littérature. PAMJ. 2018;29:167. DOI: 10.11604/pamj.2018.29.167.1850
3. Messiou C, Moskovic E, Vanel D, Morosi C, Benchimol R, Strauss D, et al. Primary Retroperitoneal Soft Tissue Sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. Eur J Surg Oncol. 2017;43(7):1191-8. DOI: 10.1016/j.ejso.2016.10.032
4. Sierra Labarta R, Gil Sanz MJ, Muñoz González G, Rioja Sanz LA. Un nuevo caso de histiocitoma fibroso maligno dependiente de cápsula renal. Actas Urol Esp. 2010 [access 22/08/2022];34(1):122-4. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062010000100023&lng=es
5. Yilmaz C, Kabatas S, Ozen OI, Gulsen S, Caner H, Altinors N. Solitary fibrous tumor. J Clin Neurosci. 2009;16(12):1578-81. DOI: 10.1016/j.jocn.2009.02.039
6. Demicco EG, Meyer C. Solitary fibrous tumor. UpToDate. 2022 [access 22/08/2022]. Available from: https://www.uptodate.com/contents/solitary-fibrous-tumor
7. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416-21. DOI: 10.1097/sla.0000000000000869
8. Trans-Atlantic RPS Working Group. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256-63. DOI: 10.1245/s10434-014-3965-2
9. Tiong SS, Dickie C, Haas RL, O’Sullivan B. The role of radiotherapy in the management of localized soft tissue sarcomas. Cancer Biol Med. 2016;13(3):373-83. DOI: 10.20892/j.issn.2095-3941.2016.0028
10. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, et al. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018;18(1):913. DOI: 10.1186/s12885-018-4829-0
11. Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy. J Surg Oncol. 2018;117(1):99-104. DOI: 10.1002/jso.24927
Descargas
Publicado
2022-12-10
Cómo citar
1.
GarcÃa-Cano Fernández AM, Boronat Catalá J, Diego GarcÃa V, Llanes González L. Presentation of three cases of primary renal sarcomas. Rev. Cubana Urol. [Internet]. 10 de diciembre de 2022 [citado 22 de diciembre de 2024];11(3):e886. Disponible en: https://revurologia.sld.cu/index.php/rcu/article/view/886
Número
Sección
Casos clínicos
Licencia
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cual estará simultáneamente sujeto a la Licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
